Legend Biotech (LEGN) Long-Term Deferred Tax (2019 - 2021)

Legend Biotech (LEGN) has 3 years of Long-Term Deferred Tax data on file, last reported at $22.8 million in Q4 2021.

• In Q4 2021, Long-Term Deferred Tax fell 25.98% year-over-year to $22.8 million; the TTM figure through Dec 2021 stood at $22.8 million (down 25.98% YoY), while the FY2021 annual figure was $22.8 million, down 25.98% from the prior year.
• Long-Term Deferred Tax eased to $22.8 million in Q4 2021, from $30.8 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $30.8 million in Q4 2020 and bottomed at $5.7 million in Q4 2019.
• A 3-year average of $19.8 million and a median of $22.8 million in 2021 frame the typical range for Long-Term Deferred Tax.
• Annual changes were most pronounced in 2020 — Long-Term Deferred Tax surged 438.86% — and 2021, when it dropped 25.98%.
• Year by year, Long-Term Deferred Tax stood at $5.7 million in 2019, then surged by 438.86% to $30.8 million in 2020, then dropped by 25.98% to $22.8 million in 2021.
• The last three Long-Term Deferred Tax figures came in at $22.8 million (Q4 2021), $30.8 million (Q4 2020), and $5.7 million (Q4 2019), per Business Quant data.

Peer Comparison